Brief: Emvision Medical Devices Says Strategic A$15.28M Investment From Keysight Technologies
29/02/2024 01:02
Feb 29 (Reuters) - EMvision Medical Devices Ltd
EMV.AX :
* STRATEGIC A$15.28M INVESTMENT FROM KEYSIGHT TECHNOLOGIES
* SECURING OF STRATEGIC A$15.28 MILLION INVESTMENT VIA A
PLACEMENT
TO KEYSIGHT TECHNOLOGIES
* PLACEMENT AT AN ISSUE PRICE OF A$2.05 PER SHARE
Source text for Eikon: ID:nASX6Rd1h6
Further company coverage: EMV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on EMvision Medical Devices
See all newsBrief: Emvision Medical Devices To Receive A$1.17M Igp Grant Instalment
Brief: Emvision Medical Devices Appoints Karl Pechmann As CFO
Brief: Emvision Medical Devices Says Oversubscribed SPP Raises A$2.0M
Australia's EMVision Medical Devices slips on discounted placement
Brief: Emvision Medical Devices To Raise A$12.0 Million Via Placement